Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-24-073000

O'Neill Vincent sold 155 shares at $1.29 ($199)

  • O'Neill Vincent acquired 521 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Vincent

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-14 Exercise or conversion : show line 1 in the form 10b5-1 +521 3,679 D
2024-06-17 Sale : show line 2 in the form 10b5-1 −155 $1.29 $199 3,524 D
Open-market sales · 155 sh · avg $1.29 · $199

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-14 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units −521 3,648 D
Loading xslF345X05/tm2417544-2_4seq1.xml…